National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience in the United States and Canada. Its portfolio of subscription-based solutions provide actionable information and analysis to healthcare organizations and payers across a range of mission-critical, constituent-related elements, including patient experience, satisfaction, community population health risks, workforce engagement, community perceptions, and physician engagement. The company offers market insights solutions that allow the tracking of awareness, perception, and consistency of healthcare brands; assessment of competitive differentiators; and enhanced segmentation tools to evaluate needs, wants, and behaviors of communities through real-time competitive assessments and enhanced segmentation tools. It also provides experience solutions, such as patient and resident experience, workforce engagement, health risk assessments, transitions, and improvement tools. The company offers transitions solutions, which enable organizations to identify and manage high-risk patients to reduce readmissions, increase patient satisfaction and support safe care transitions; and risk assessment solutions that enable clients to segment populations and manage care for those who are most at risk, engage individuals, enhance preventative care, and manage wellness programs. It provides transparency solutions that allow healthcare organizations to share picture of their organization and ensure content informs in consumer decision-making; and governance solutions for not-for-profit hospital and health system boards of directors, executives, and physician leadership. The company serves integrated health systems and post-acute providers, such as home health, long term care, hospice, and payer organizations. The company was founded in 1981 and is headquartered in Lincoln, Nebraska.
Industry, Sector and Symbol
Industry Diagnostics & Research
Sub-IndustryN/A
SectorMedical
CIKN/A
PhoneN/A
Debt
Price-To-Earnings
Sales & Book Value
Annual SalesN/A
Profitability
Miscellaneous
EmployeesN/A
Next Earnings Date8/6/2019 (Estimated)
OptionableNot Optionable
NationalResearchCorp . (NYSE:NRC) Frequently Asked Questions
What is NationalResearchCorp .'s stock symbol?
NationalResearchCorp . trades on the New York Stock Exchange (NYSE) under the ticker symbol "NRC."
How often does NationalResearchCorp . pay dividends? What is the dividend yield for NationalResearchCorp .?
NationalResearchCorp . declared a quarterly dividend on Thursday, February 14th. Stockholders of record on Friday, March 29th will be given a dividend of $0.19 per share on Monday, April 15th. This represents a $0.76 annualized dividend and a dividend yield of 1.48%. The ex-dividend date of this dividend is Thursday, March 28th. View NationalResearchCorp .'s Dividend History.
How were NationalResearchCorp .'s earnings last quarter?
NationalResearchCorp . (NYSE:NRC) issued its quarterly earnings data on Tuesday, May, 7th. The company reported $0.32 earnings per share for the quarter, beating the Thomson Reuters' consensus estimate of $0.31 by $0.01. The firm earned $31.48 million during the quarter, compared to analyst estimates of $33.50 million. View NationalResearchCorp .'s Earnings History.
When is NationalResearchCorp .'s next earnings date?
What is the consensus analysts' recommendation for NationalResearchCorp .?
1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for NationalResearchCorp . in the last year. There are currently 1 hold rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for NationalResearchCorp ..
Has NationalResearchCorp . been receiving favorable news coverage?
Media stories about NRC stock have been trending somewhat negative on Sunday, according to InfoTrie. The research group identifies negative and positive press coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. NationalResearchCorp . earned a media sentiment score of -1.8 on InfoTrie's scale. They also gave headlines about the company a news buzz of 9.0 out of 10, indicating that recent press coverage is extremely likely to have an impact on the company's share price in the next several days.
Who are some of NationalResearchCorp .'s key competitors?
Some companies that are related to NationalResearchCorp . include Integral Diagnostics (IDX), Senseonics (SENS), Senseonics (SENS), Akumin (AKU), Palatin Technologies (PTN), Renalytix Ai (RENX), Profound Medical (PRN), MaxCyte (MXCT), Yourgene Health (YGEN), Oncimmune (ONC), Lexagene (LXG), Oncosil Medical (OSL), Sernova (SVA), SQI Diagnostics (SQD) and Deepmatter Group (DMTR).
What other stocks do shareholders of NationalResearchCorp . own?
Who are NationalResearchCorp .'s key executives?
NationalResearchCorp .'s management team includes the folowing people:
- Mr. Michael D. Hays, Founder, CEO & Director (Age 63)
- Mr. Steven D. Jackson, Pres (Age 42)
- Mr. Kevin R. Karas CPA, Principal Accounting Officer, Sr. VP of Fin., CFO, Treasurer & Sec. (Age 60)
- Ms. Helen Hrdy, Sr. VP of Client Services
Who are NationalResearchCorp .'s major shareholders?
NationalResearchCorp .'s stock is owned by a number of of institutional and retail investors. Top institutional investors include Kayne Anderson Rudnick Investment Management LLC (11.66%), Dimensional Fund Advisors LP (2.97%), BlackRock Inc. (2.66%), Conestoga Capital Advisors LLC (2.46%), Renaissance Technologies LLC (1.98%) and Northern Trust Corp (0.70%). Company insiders that own NationalResearchCorp . stock include K/I/E Trust Under Agreement 10, K/I/E/Trust Under Agreement 3/ and Kevin R Karas. View Institutional Ownership Trends for NationalResearchCorp ..
Which institutional investors are selling NationalResearchCorp . stock?
NRC stock was sold by a variety of institutional investors in the last quarter, including Kayne Anderson Rudnick Investment Management LLC, BlackRock Inc., Morgan Stanley, Neuberger Berman Group LLC, First Quadrant L P CA, Oxford Asset Management LLP, Comerica Bank and Northern Trust Corp. Company insiders that have sold NationalResearchCorp . company stock in the last year include K/I/E Trust Under Agreement 10, K/I/E/Trust Under Agreement 3/ and Kevin R Karas. View Insider Buying and Selling for NationalResearchCorp ..
Which institutional investors are buying NationalResearchCorp . stock?
NRC stock was bought by a variety of institutional investors in the last quarter, including Renaissance Technologies LLC, Geode Capital Management LLC, Parametric Portfolio Associates LLC, Sawgrass Asset Management LLC, Charles Schwab Investment Management Inc., Dimensional Fund Advisors LP, Conestoga Capital Advisors LLC and PNC Financial Services Group Inc.. View Insider Buying and Selling for NationalResearchCorp ..
How do I buy shares of NationalResearchCorp .?
Shares of NRC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is NationalResearchCorp .'s stock price today?
One share of NRC stock can currently be purchased for approximately $51.29.
How big of a company is NationalResearchCorp .?
NationalResearchCorp . has a market capitalization of $1.27 billion.
What is NationalResearchCorp .'s official website?
MarketBeat Community Rating for NationalResearchCorp . (NYSE NRC)
MarketBeat's community ratings are surveys of what our community members think about NationalResearchCorp . and other stocks. Vote "Outperform" if you believe NRC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe NRC will underperform the S&P 500 over the long term. You may vote once every thirty days.
